Antiplasmodial and antidiabetic activities of ethanolic leaf extract of Heinsia crinata.

The ethanolic leaf extract of Heinsia crinata, grown particularly for the leaf in Niger Delta region of Nigeria, was evaluated for antiplasmodial activity in Plasmodium berghei-infected mice as well as for hypoglycemic and antidiabetic activities in alloxan-induced diabetic rats. H. crinata (450-1,350 mg/kg/day) exhibited significant (P < .05) blood schizonticidal activity in both the 4-day early infection test and established infection with a considerable mean survival time, though not comparable to that of the standard drug, chloroquine (5 mg/kg/day). Treatment of alloxan-induced diabetic rats with the leaf extract caused a significant (P < .01) reduction in fasting blood glucose levels of normal and alloxan-induced diabetic rats both in an acute study and with prolonged treatment (2 weeks). The activity of the extract was comparable to that of the reference drug, glibenclamide, during the acute study but was not comparable to that of the standard drug during prolonged treatment. The results suggest that the leaf extract of H. crinata possesses significant (P < .05) antiplasmodial as well as hypoglycemic and antidiabetic effects that can be employed in health care.

Evaluation of the in vivo antimalarial activity of ethanolic leaf and stembark extracts of Anthocleista djalonensis.

OBJECTIVE: To evaluate the in vivo antimalarial activities of ethanolic leaf and stembark extracts of Anthocleista djalonensis used traditionally as malarial remedy in Southern Nigeria in mice infected with Plasmodium berghei berghei. METHODS: The ethanolic extracts of the A. djalonensis leaf (1000 - 3000 mg/kg/day) and stembark (220 - 660 mg/kg/day) were screened for blood schizonticidal activity against chloroquine-sensitive P. berghei in mice. The schizonticidal effect during early and established infections was investigated. RESULTS: The A. djalonensis leaf extract (1000 - 3000 mg/kg/day) exhibited a significant antiplasmodial activity both in the 4-day early infection test and in the established infection with a considerable mean survival time, which was incomparable to that of the standard drug, chloroquine (5 mg/kg/day). The stembark extract (220 - 660 mg/kg/day) also demonstrated a promising blood schizontocidal activity in early and established infections. CONCLUSION: These plant extracts possess considerable antiplasmodial activities, which justify their use in ethnomedicine and can be exploited in malaria therapy.